Literature DB >> 3000835

Decreased beta-adrenergic responsiveness during senescence.

P J Scarpace.   

Abstract

The capacity of the myocardium to respond to catecholamines is diminished in senescence. The intrinsic inotropic and chronotropic responses of the contractile elements to direct stimulation are unaltered with age, which suggests that the mechanism for diminished responsiveness lies in the sequence of events between the beta-adrenergic receptor and effector site. In a series of investigations of rat myocardial, rat lung, and human lymphocyte alpha- and beta-adrenergic function with age, it has been demonstrated that 1) there are no changes in either alpha 2- or beta-adrenergic receptor density or receptor antagonist affinity, 2) there is decreased beta-adrenergic receptor-agonist affinity with a corresponding decrease in the ability to form the high-affinity binding complex, 3) there is no change in alpha 2-adrenergic receptor agonist affinity, 4) there is decreased NaF- and hormone-stimulated adenylate cyclase activity, 5) there is decreased nucleotide regulatory protein function in the rat myocardium, 6) there is decreased catalytic unit function, and 7) there is decreased translocation of membrane-bound protein kinase. These changes in the beta-adrenergic stimulatory pathway may account for the diminished myocardial catecholamine responsiveness associated with aging.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000835

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  8 in total

1.  Serial changes in the myocardial beta-adrenergic signalling system in two models of non-insulin dependent diabetes mellitus.

Authors:  B Huisamen; E Marais; S Genade; A Lochner
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Beta-adrenergic receptor activity of cerebral microvessels is reduced in aged rats.

Authors:  A D Mooradian; P J Scarpace
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

3.  Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells.

Authors:  P Y D'avis; C R Frazier; J R Shapiro; N S Fedarko
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 4.  Mechanisms of age-related endocrine alterations. Part II.

Authors:  A D Mooradian
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 5.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 6.  Key factors in the treatment of the elderly hypertensive.

Authors:  J L Dall
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

7.  Evaluation of shock-related cardiotoxic peptide.

Authors:  H Kawabata; M Yahagi; K Mizumachi; S Tezuka
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

8.  Age-related changes in human oestrogen receptor alpha function and levels in osteoblasts.

Authors:  M A Ankrom; J A Patterson; P Y d'Avis; U K Vetter; M R Blackman; P D Sponseller; M Tayback; P G Robey; J R Shapiro; N S Fedarko
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.